<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Amryt Pharma boasts 20% year-to-date revenue bounce	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/amryt-pharma-boasts-20-year-to-date-revenue-bounce/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/amryt-pharma-boasts-20-year-to-date-revenue-bounce/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 12 Nov 2019 12:30:09 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: IMCD boasts 15% profit growth during first three quarters - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/amryt-pharma-boasts-20-year-to-date-revenue-bounce/#comment-12547</link>

		<dc:creator><![CDATA[IMCD boasts 15% profit growth during first three quarters - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 12 Nov 2019 12:30:09 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=23558#comment-12547</guid>

					<description><![CDATA[[&#8230;] in drug and chemical news, Amryt Pharma Holdings Ltd (LON: AMYT), Curetis NC (AMS: CURE) and Integumen PLC (LON: SKIN) also boasted revenue [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] in drug and chemical news, Amryt Pharma Holdings Ltd (LON: AMYT), Curetis NC (AMS: CURE) and Integumen PLC (LON: SKIN) also boasted revenue [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
